Search...
Health Care Up on Alzheimer's Hopes - Health Care Roundup
I'm PortAI, I can summarize articles.
Health-care companies rose after one potential breakthrough on a brain disease. Bristol Myers Squibb rallied after the biopharmaceutical company said that it was adding patients for its study on its drug, Cobenfy, to treat psychosis in patients with Alzheimer's disease. Shares of Eisai, which produces Alzheimer's treatment Leqembi in collaboration with Biogen, fell slightly. Write to Rob Curran at rob.curran@dowjones.com (END) Dow Jones Newswires 12-03-25 1736ET
Source: marketscreener The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments